media

Markets

Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address

Registered & Corporate Office : 717/718, Maker Chambers V, , Nariman Point,
Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

Universal Capital Securities Pvt. Ltd.
C 101, 247 Park, LBS Road, Vikhroli West,
Mumbai,400083,Maharashtra
Tel: 022-28207203
Fax: 28207207

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal Ltd. has submitted to BSE the Shareholding Patt...

15-Apr-2024|11:00PM

As of March 2024, 68.85% is owned by Indian Promoters and 31.15% by Public.

Hikal Ltd. - Certificate under SEBI (Depositories and...

15-Apr-2024|7:47PM

Hikal Limited has informed the Exchange about Certificate under SEBI (Depos

Hikal Ltd. - Compliances-Certificate under Reg. 74 (5...

15-Apr-2024|7:46PM

Certificate under Regulation 74(5) of SEBI (Depositories and Participants)

Hikal Ltd. - Compliance Certificate Under Regulation ...

15-Apr-2024|7:16PM

Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations a

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug47.85134.24
Aarti Drug499.504,592.15
Aarti Pharma500.504,535.83
Abbott India26,205.0055,683.80
Accent Micro272.45573.32

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Tata Sm..92.631.47
Motilal..1.470.18
Motilal..0.010.10
Groww N..0.010.01

Board Meetings

DatePurpose
08/02/2024Quarterly Results &..
02/11/2023Quarterly Results
08/08/2023Quarterly Results
29/05/2023Audited Results & F..
02/02/2023Quarterly Results &..